The type II isopentenyl diphosphate:dimethylallyl diphosphate isomerase (IDI-2) catalyzes the reversible isomerization of isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP). Although a growing body of experiments have suggested that the flavin coenzyme of IDI-2 serves a novel function as an acid-base catalyst, the detailed reaction mechanism of IDI-2 is still unknown. In this paper, a combined quantum-mechanical/molecular-mechanical (QM/MM) approach has been applied to investigate the detailed reaction mechanism of IDI-2. The one-base mechanism in which the N-5 nitrogen of the zwitterionic form of reduced FMN acts as the acid-base catalyst has been supported by our computational results, and a IPP-FMN adduct is also proposed for the first time. The mechanistic details including the fundamental reaction pathways, the complete energy profiles of the whole catalytic cycle, and the specific role of the coenzyme and key residues are all obtained. It is proved that IDI-2 employs novel flavin chemistry with the coenzyme acting as a general acid-base catalyst.
Introduction
Isoprenoids are a large and structurally diverse class of metabolites which are essential to life.
1-3 Sterols, carotenoids, dolichols, ubiquinones, and the lipophilic side chains of prenylated proteins are included in this class, which are utilized in a variety of ways by living organisms, functioning as hormones, vitamins, visual pigments, pheromones, toxins, and components of cell membranes. All isoprenoids derive from the same ve-carbon building blocks, isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). Isopentenyl diphosphate:dimethylallyl diphosphate isomerases (IDI) catalyze the reversible isomerization of IPP and DMAPP, 4 as described in Scheme 1.
Two structurally distinct IDIs have been identied. The structure and mechanism of type I IDI (IDI-1) have been extensively studied. IDI-1 requires two divalent metal ions (Mg 2+ and Zn 2+ ) for activity. [5] [6] [7] [8] [9] The Mg 2+ ion promotes substrate binding, while the Zn 2+ ion binds to a hexacoordinate site in the enzyme that contains an essential glutamate residue. This glutamate, in conjunction with a nearby tyrosine residue, acts as a catalytic acid, protonating the double bond of IPP to generate a carbocation intermediate. Subsequent removal of the pro-R C2 proton by a conserved cysteine residue completes the isomerization reaction. In contrast to IDI-1, the type II enzyme (IDI-2) requires both a divalent metal ion and reduced avin mononucleotide (FMN) coenzyme. [10] [11] [12] [13] However, mechanistic studies on IDI-2 remain spare, and it is still unclear what role the reduced avin coenzyme plays in this isomerization reaction without net redox change.
To date, several IDI-2 homologues have been puried and characterized to different extents. 14, 15 But most of reported studies have focused on the biochemical characterization of the puried proteins. IDI-2 is a member of the (S)-a-hydroxy acid dehydrogenase superfamily, which has been puried from several pathogenic bacteria including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis. The proteins crystallized as typical a8b8 triosephosphate isomerase (TIM) barrels, and one molecule of FMN was bound per monomer and located in the standard phosphate binding (SPB) region of the TIM barrel.
Based on the crystal structures and experimental studies, several proposals for the role of the avin have been discussed for IDI-2, 16-19 as described in Scheme 2. For the inactivity of apoenzyme reconstituted with cofactor analogues such as 5-deaza-FMN, a radical-mediated mechanism was initially proposed.
16,17
However, the radical substrate intermediates were not detected in sopped-ow studies under single turn over conditions. Alternatively, a protonation-deprotonation mechanism was suggested for IDI-2. 19 The conserved glutamine residue (Gln154 in S. aureus or Gln160 in S. shibatae IDI-2) is optimally positioned (at a distance of 3.4-4.5Å) to mediate the proton transfer at C4 position of IPP/ DMAPP. While glutamine is not a typical acid/base catalyst, it could be part of a proton relay consisting of conserved amino acid residues (specically His11 and Glu229 in S. shibatae). Indeed, sitedirected mutagenesis of this glutamine residue led to a mutant enzyme with a substantially lowered k cat value and an unperturbed K M value for IPP. Another possibility is that the reduced FMN directly participates in acid-base catalysis, either with the assistance of an amino acid group or by serving as both an acid and a base via FMNH2 or its zwitterionic tautomer. 18, 20 Considering the short distance between N5 of FMN and C4 of IPP, it is conceivable that N5 is the catalyst for both proton transfers at C2 and C4. In the studies of Thermus thermophilus IDI-2, C. Dale Poulter discovered that the olenic hydrogens of a vinyl thiomethyl analogue of isopentenyl diphosphate exchanged with solvent when the enzyme was incubated with D2O without concomitant isomerization of the double bond. These results suggest the enzyme-catalyzed isomerization reaction is not concerted. A substantial accumulation of positive charge on the reduced FMN during turnover as indicated by the kinetic linear free energy relationship (LFER) studies is also consistent with the role of N5 as a putative general acid/base catalyst. The latter observation is likely due to the transfer of the pro-R C2-H of IPP to the N5 atom of the reduced FMN coenzyme, which is at least partially rate limiting in steady state IDI-2 turnover based on substrate deuterium kinetic isotope effect (KIE) studies.
20,21
As described above, the reaction mechanism of IDI-2 is still controversial. In this paper, a combined quantum mechanics and molecular mechanics (QM/MM) study on IDI-2 is presented and different pathways are devised. The mechanistic details of the reaction, including the detailed energetic prole, structures of the intermediates, transition states along the reaction pathways and the role of FMN are illustrated.
Computational methods
The crystal structure of IDI in complex with reduced FMN and IPP (PDB ID:2ZRY) 5 was used to construct the computational model. The molecular dynamics simulations were done with CHARMM27 force eld as implemented in the CHARMM program. 22 The protonation states of the titratable residues were determined according to the experimental condition and the PROPKA method. 23, 24 As for FMN, its different protonation states will be discussed in the following section. The missing hydrogen atoms were added using the HBUILD facility. Each system was neutralized by adding Na + ion at random position, and solvated into a water sphere of radius centered on the C1 atom of the substrate. To relax the system, preliminary structural optimization was rstly carried out, then a 8 ns simulation was performed to equilibrate the system. A relative smooth RMSD (the root-mean-squared deviation) curve to represent equilibration of protein backbone (shown in Fig. S1 †) was obtained. It is shown that the dynamics trajectory was basically stable aer 6 ns, and there would be no major uctuations for the protein backbone unless undergoing reaction. A representative initial structure selected from MD trajectory is important for obtaining a meaningful energy barrier. In our calculations, a total of 11 snapshots were extracted from the MD trajectory for the following QM/MM calculations. The superposition of QM region from 11 obtained structures was displayed in Fig. S2 . † To nd a representative initial congu-ration, the RMSDs of 11 structures relative to the average one were rstly calculated ( Fig. S2 †) , then a presentative structure derived from 5.6 ns of MD trajectory was selected for the following step.
In QM/MM calculations, the QM subsystem contains the substrate (IPP), coenzyme FMN, an Mg 2+ , one water molecule and the sidechains of Lys193, Ser195, and His11 (depicted in Fig. 2 ) which directly participate in the catalysis or make a signicant impact on the distribution of electron density in the active site. MM subsystem includes all the other atoms and solvent. The QM/MM calculations were performed with the ChemShell package 25 which integrates TURBOMOLE 26 and DL-PLOY programs. 27 The B3LYP functional and 6-31G (d, p) basis set were used for the QM part, and the CHARMM22 force eld for the MM part. An electronic embedding scheme 28 which incorporates the MM charges into the one-electron Hamiltonian of the QM treatment and hydrogen link atoms with charge shi model for the QM/MM boundary were adopted in the QM/ MM treatment. During the geometry optimization, the QM subsystem and the MM atoms within a distance of 12Å of N atom of IPP were allowed to relax, whereas the remaining MM atoms were kept frozen. The hybrid delocalized internal coordinates (HDLC) optimizer 29 in ChemShell was employed for geometry optimizations. A quasi-Newton limited memory Broyden-Fletcher-Goldfarb-Shanno (L-BFGS) algorithm 29 was used for minima search. In the transition state search, the highest point on the potential energy prole along the reaction coordinate was chosen to be optimized with partitioned rational function optimization (P-RFO) method 29 and characterized by a single negative eigenvalue. The electronic embedding scheme and the hydrogen link atoms with charge shi model for QM/ MM boundary were applied in the QM/MM treatment. Finally, a high-level single point electronic energy calculation was performed at a larger basis set 6-311++G (d, p) to obtain accurate energies. All the energies reported herein were corrected by zero-point vibrational effects.
Results and discussion

Structure of enzyme-substrate complex
The reported crystal structure of IDI-2 and the active pocket with the key surrounding residues are shown in Fig. 1 . In the crystal structure, the asymmetric unit contains four monomers that are related by a non-crystallographic 4-fold rotation, and each monomer contains a regular triose-phosphate isomerase Alternatively, the N-1 nitrogen and N-5 nitrogen are likely to act as a pair of acid/base, along with the tautomeric rearrangement of reduced avin. The stationary points concerning path B are shown in Fig. 5 . In the reactant complex (React B ), the distance between H and C4 is 3.95Å, and the C2 atom of IPP positions a distance of 3.81Å from the C4A atom of FMNH2. In the rst step, the proton transfer and formation of bond C4A(FMNH2)-C3(IPP) are considered to be a concerted mechanism. In the transition state (TS1 B ), the distances of N1-H and H-C4(IPP) is . Notably, it is 15 kcal mol À1 higher than the rate-limiting step in path A. In the second step, the enzyme undergoes process of the hydrogen transfer and C4A(FMNH2)-C3(IPP) bond breakage concertedly. In TS2 B , the distances of N5-H and H-C2(IPP) is 1.39Å and 1.50 A, respectively, and the C4A(FMNH2)-C3(IPP) bond is 2.93Å. It is suggested that C4A(FMNH2)-C3(IPP) bond is already broken. Finally, the product DMAP is formed. The calculated energy barrier for this step is 21.3 kcal mol
À1
. The corresponding energy prole along the reaction path is presented in Fig. 6 . The energy values displayed in the Fig. 6 are taken relative to the reactant, and the energy barriers are calculated relative to the preceding intermediate.
We also explored another possibility that the anionic reduced FMNH À participates in acid-base catalysis with the assistance of an amino acid group. The optimized structure taken from the reactive pocket of IDI is shown in Fig. 7 . Compared with the crystal structure, the active pocket of model B is located at the same position, but the binding mode is a little bit different. The C2-C3 bond of the substrate has rotated about 180 . As described in the Scheme 3, when the N-5 of FMNH À attracts a proton from the C2 of IPP, a proton from an amino acid transfers to the double bond of IPP concertedly. Notably, there are several charged and polar residues surrounding the double bond of IPP, including Lys193, His155, and Ser195. Lys193 is far away from IPP with the distance from C-4 of the substrate being 5.04Å. Obviously, His155 and Ser 195 cannot act as a general acid-base catalyst for C-4 of IPP because they cannot access the reaction site with the pro-R specicity. Unfortunately, no putative proton donor and acceptor can be identied to support this mechanism. Our QM/MM results have provided much mechanistic information for the unusual avoenzyme IDI-2. The mechanistic details support the mechanism of model A. Because of the ability of FMN to accept and donate either one or two protons according to the nitrogen atoms of the avin ring, the coenzyme of FMN is supposed to participate in the enzymatic reaction directly. The N5 atom of FMN is properly positioned to perform a similar role as an active site acid-base catalyst. The N5 atom loses a proton to the C4 atom of IPP in the rst step, and then attracts a proton from the C2 atom of IPP. FMN-IPP adduct is formed as an intermediate during the catalysis. Interestingly, Eguchi and coworkers 30 have recently found that an epoxide analogue of IPP binds inclose proximity to the avin ring and suggests that electron density is capable of accumulating at N5. Our results support that the substrate and the avin ring are easily form a cavalent adduct according to C4A-C3 bond. Our results are also consistent with the linear free energy relationships (LFER) studies which suggest that the IDI-2 chemical mechanism involves general base catalysis by the N5 atom of the reduced avin coenzyme. The fact that IDI-1 and IDI-2 catalyze isomerization by totally different mechanisms has also been demonstrated by these results.
Actually, avin coenzymes play multiple roles in biological systems. In the catalytic mechanism of IDI-2, the role of N5 acting as a putative general acid/base catalyst has been approved by our QM/MM calculations. Meanwhile, an adduct is rstly proposed and obtained in the catalytic mechanism. Though the involvement of a formal reduced N5 anion in acid/base chemistry has never been demonstrated in avin-dependent enzyme catalysis, such as a species could both electrostatically stabilize a developing substrate carbocation and act as a general base. Acyl-CoA dehydrogenases are capable of catalyzing the one and two-electron oxidation/reduction reactions. [31] [32] [33] While in CDP-6-deoxy-L-threo-D-glycero-4-hexulose-3-dehydrase reductase, avin acts as a redox mediator between two-electron and one-electron transfer reactions. 34 In some other avin coenzymes, avin mononucleotide or avin adenine dinucleotide are not involved in redox chemistry, they may electrostatically stabilize the reaction intermediates. 35, 36 In UDP-galactopyranose mutase, avin acts as a covalent catalyst, facilitating the ring contraction through the formation of an N5 adduct. Excitingly, the behavior of the avin coenzyme during IDI-2 catalysis is quite different to that observed in the reactions catalyzed by these avoenzymes.
Conclusion
Despite its extreme importance, the mechanism of IDI-2 has not yet been determined. In this study, QM/MM method was rstly employed to investigate the detailed mechanism of IDI-2 by three models. Path A is supported to be the minimum energy pathway by our QM/MM calculations. In this path, IDI-2 employs novel avin chemistry, with the N5 atom of FMN acting as a general acid/base catalyst. In the rst step, the proton transfer of H(N5) and the formation C4A(FMNH2)-C3(IPP) bond occur concertedly to form the FMN-IPP adduct with an energy barrier of 18.0 kcal mol
À1
. It is notably that the intermediate of FMN-IPP adduct with the C4A-C3 bond is found for the rst time. In the second step, the enzyme undergoes process of the hydrogen transfer and C4A(FMNH2)-C3(IPP) bond breakage concertedly, corresponding to an energy barrier of 18.8 kcal mol
. Path B has been identied to be a high-energy pathway. The rate-limiting step of formation of IPP-FMN adduct undergoes an energy barrier of 33.8 kcal mol
. In path C, there is no putative proton donor and acceptor can be identied to support this mechanism. It is clear that our study elucidated the reversible isomerization of IPP and DMAPP catalyzed by this unusual enzyme at the atomistic level, which could further provide useful information for the development of new antibiotics.
